Using yeast to understand drugs that target topoisomerases

Annals of the New York Academy of Sciences

Volumn 803, Issue , 1996, Pages 32-43

  Nitiss, John L ^a   Rose, Angela ^a   Sykes, Karin C ^a,b   Harris, James ^a   Zhou, Junfang ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING);

CELL KILLING; CONFERENCE PAPER; CYTOTOXICITY; DNA DAMAGE; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; DRUG TARGETING; GENE; GENETIC TRANSCRIPTION; NONHUMAN; SACCHAROMYCES CEREVISIAE; YEAST;

EID: 0030454032     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb26374.x     Document Type: Conference Paper

References (62)

1. LIU, L. F. 1989. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58: 351-375.
2. LIU, L. F. & P. D'ARPA. 1992. Topoisomerase-targeting antitumor drugs: Mechanisms of cytotoxicity and resistance. Important Adv. Oncol.: 79-89.
3. POMMIER, Y. 1993. DNA topoisomerase I and II in cancer chemotherapy: Update and perspectives. Cancer Chemother. Pharmacol. 32: 103-108.
4. CORBETT, A. H. & N. OSHEROFF. 1993. When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. Chem. Res. Toxicol. 6: 585-597.
5. FROELICH-AMMON, S. J. & N. OSHEROFF. 1995. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270: 21429-21432.
6. NITISS, J. L. 1994. Using yeast to study resistance to topoisomerase II-targeting drugs. Cancer Chemother. Pharmacol. 34(Suppl.): S6-13.
7. NITISS, J. L. 1994. Roles of DNA topoisomerases in chromosomal replication and segregation. Adv. Pharmacol. 29A: 103-134.
8. NITISS, J. L. 1994. Yeast as a genetic model system for studying topoisomerase inhibitors. Adv. Pharmacol. 29B: 201-226.
9. SVEJSTRUP, J. Q., K. CHRISTIANSEN, I. I. GROMOVA, A. H. ANDERSEN & O. WESTERGAARD. 1991. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. J. Mol. Biol. 222: 669-678.
10. KJELDSEN, E., J. Q. SVEJSTRUP, I. I. GROMOVA, J. ALSNER & O. WESTERGAARD. 1992. Camptothecin inhibits both the cleavage and religation reactions of eukaryotic DNA topoisomerase I. J. Mol. Biol. 228: 1025-1030.
11. OSHEROFF, N., E. L. ZECHIEDRICH & K. C. GALE. 1991. Catalytic function of DNA topoisomerase II. Bioessays. 13: 269-273.
12. GOTO, T. & J. C. WANG. 1985. Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. Proc. Natl. Acad. Sci. USA 82: 7178-7182.
13. THRASH, C., K. VOELKEL, S. DINARDO & R. STERNGLANZ. 1984. Identification of Saccharomyces cerevisiae mutants deficient in DNA topoisomerase I activity. J. Biol. Chem. 259: 1375-1377.
14. HOLM, C., T. GOTO, J. C. WANG & D. BOTSTEIN. 1985. DNA topoisomerase II is required at the time of mitosis in yeast. Cell 41: 553-563.
15. NITISS, J. L., Y. X. LIU, P. HARBURY, M. JANNATIPOUR, R. WASSERMAN & J. C. WANG. 1992. Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Res. 52: 4467-4472.
16. ELSEA, S. H., N. OSHEROFF & J. L. NITISS. 1992. Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast. J. Biol. Chem. 267: 13150-13153.
17. NITISS, J. L., Y. X. LIU & Y. HSIUNG. 1993. A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: A genetic system for determining the targets of topoisomerase II inhibitors. Cancer Res. 53: 89-93.
18. ENG, W. K., L. FAUCETTE, R. K. JOHNSON & R. STERNGLANZ. 1988. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34: 755-760.
19. NITISS, J. & J. C. WANG. 1988. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA 85: 7501-7505.
20. JANNATIPOUR, M., Y. X. LIU & J. L. NITISS. 1993. The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine. J. Biol. Chem. 268: 18586-18592.
21. ISHIDA, R., M. HAMATAKE, R. A. WASSERMAN, J. L. NITISS, J. C. WANG & T. ANDOH. 1995. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Cancer Res. 55(11): 2299-2303.
22. BERGER, N. A., S. CHATTERJEE, J. A. SCHMOTZER & S. R. HELMS. 1991. Etoposide (VP-16-213)-induced gene alterations: Potential contribution to cell death. Proc. Natl. Acad. Sci. USA 88: 8740-8743.
23. HASHIMOTO, H., S. CHATTERJEE & N. A. BERGER. 1995. Mutagenic activities of topoisomerase inhibitors. Clin. Cancer Res. 1: 369-376.
24. BALZI, E. & A. GOFFEAU. 1991. Multiple or pleiotropic drug resistance in yeast. Biochim. Biophys. Acta 1073: 241-252.
25. BALZI, E. & A. GOFFEAU. 1995, Yeast multidrug resistance: The PDR network. J. Bioenerg. Biomembr. 27: 71-76.
26. BALZI, E., M. WANG, S. LETERME, L. VAN DYCK & A. GOFFEAU. 1994. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269: 2206-2214.
27. PRASAD, R., P. DE WERGIFOSSE, A. GOFFEAU & E. BALZI. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27: 320-329.
28. HIRATA, D., K. YANO, K. MIYAHARA & T. MIYAKAWA. 1994. Saccharomyces cerevisiae YDRI, which encodes a member of the ATP-binding cassette (ABC) superfamily, is required for multidrug resistance. Curr. Genet. 26: 285-294.
29. LEONARD, P. J., P. K. RATHOD & J. GOLIN. 1994. Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux. Antimicrob. Agents Chemother. 38: 2492-2494.
30. HSIANG, Y. H., R. HERTZBERG, S. HECHT & L. F. LIU. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260: 14873-14878.
31. HSIANG, Y. H. & L. F. LIU. 1989. Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. J. Biol. Chem. 264: 9713-9715.
32. BERTRAND, R., M. SARANG, J. JENKIN, D. KERRIGAN & Y. POMMIER. 1991. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51: 6280-6285.
33. KAMESAKI, S., H. KAMESAKI, T. J. JORGENSEN, A. TANIZAWA, Y. POMMIER & J. COSSMAN. 1993. bcl-2 Protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair [published erratum appears in Cancer Res. 1994, 54(11): 3074]. Cancer Res. 53: 4251-4256.
34. SOLARY, E., R. BERTRAND & Y. POMMIER. 1994. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia 8: 792-797.
35. D'ARPA, P., C. BEARDMORE & L. F. LIU. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50: 6919-6924.
36. TSAO, Y. P., P. D'ARPA & L. F. LIU. 1992. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: Altered regulation of p34cdc2/cyclin B. Cancer Res. 52: 1823-1829.
37. ZHANG, H., P. D'ARPA & L. F. LIU. 1990. A model for tumor cell killing by topoisomerase poisons. Cancer Cells 2: 23-27.
38. POMMIER, Y., F. LETEURTRE, M. R. FESEN, A. FUJIMORI, R. BERTRAND, E. SOLARY, G. KOHLHAGEN & K. W. KOHN. 1994. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12: 530-542.
39. CHEN, A. Y. & L. F. LIU. 1994. DNA topoisomerases: Essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34: 191-218.
40. DOWNES, C. S. & R. T. JOHNSON. 1988. DNA topoisomerases and DNA repair. Bioessays 8: 179-184.
41. MATTERN, M. R., R. F. PAONE & R. S. DAY. 1982. Eukaryotic DNA repair is blocked at different steps by inhibitors of DNA topoisomerases and of DNA polymerases alpha and beta. Biochim. Biophys. Acta 697: 6-13.
42. WEBB, M. L. & S. T. JACOB. 1988. Inhibition of RNA polymerase I-directed transcription by novobiocin. Potential use of novobiocin as a general inhibitor of eukaryotic transcription initiation. J. Biol. Chem. 263: 4745-4748.
43. DOWNES, C. S., M. J. ORD, A. M. MULLINGER, A. R. COLLINS & R. T. JOHNSON. 1985. Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerases. Carcinogenesis 6: 1343-1352.
44. COTTEN, M., D. BRESNAHAN, S. THOMPSON, L. SEALY & R. CHALKLEY. 1986. Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase. Nucleic Acids Res. 14: 3671-3686.
45. TAN, K. B., M. R. MATTERN, R. A. BOYCE & P. S. SCHEIN. 1987. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc. Natl. Acad. Sci. USA 84: 7668-7671.
46. TAN, K. B., S. R. PER, R. A. BOYCE, C. K. MIRABELLI & S. T. CROOKE. 1988. Altered expression and transcription of the topoisomerase II gene in nitrogen mustard-resistant human cells [published erratum appears in Biochem Pharmacol 1989 May 1; 38(9): 1541]. Biochem Pharmacol. 37: 4413-4416.
47. BARRET, J. M., P. CALSOU, A. K. LARSEN & B. SALLES. 1994. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity. Mol. Pharmacol. 46: 431-436.
48. MADDEN, K. R., L. STEWART & J. J. CHAMPOUX. 1995. Preferential binding of human topoisomerase I to superhelical DNA. EMBO J. 14: 5399-5409.
49. ENG, W. K., S. D. PANDIT & R. STERNGLANZ. 1989. Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I. J Biol Chem. 264: 13373-13376.
50. LYNN, R. M., M. A. BJORNSTI, P. R. CARON & J. C. WANG. 1989. Peptide sequencing and site-directed mutagenesis identify tyrosine- 727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Proc. Natl. Acad. Sci. USA 86: 3559-3563.
51. VOSBERG, H. P. 1985. DNA topoisomerases: Enzymes that control DNA conformation. Curr. Topics Microbiol. Immunol. 114: 19-102.
52. FERRO, A. M. & B. M. OLIVERA. 1984. Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. J. Biol. Chem. 259: 547-554.
53. JONGSTRA-BILEN, J., M. E. ITTEL, C. NIEDERGANG, H. P. VOSBERG & P. MANDEL. DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation). Eur. J. Biochem. 136: 391-396.
54. CHATTERJEE, S., M. F. CHENG, D. TRIVEDI, S. J. PETZOLD & N. A. BERGER. 1989. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun. 1: 389-394.
55. CHRISTIANSEN, K., A. B. SVEJSTRUP, A. H. ANDERSEN & O. WESTERGAARD. 1993. Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination. J. Biol. Chem. 268: 9690-9701.
56. BULLOCK, P., J. J. CHAMPOUX & M. BOTCHAN. 1985. Association of crossover points with topoisomerase I cleavage sites: A model for nonhomologous recombination. Science 230: 954-958.
57. BULLOCK, P. A. 1985. SV40 Excision and Integration. Dis. Abstr. Int. (Sci). 46: 1026B 1985.
58. WORLAND, S. T. & J. C. WANG. 1989. Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J. Biol. Chem. 264: 4412-4416.
59. DARBY, M. K., B. SCHMITT, J. JONGSTRA-BILEN & H. P. VOSBERG. 1985. Inhibition of calf thymus type II DNA topoisomerase by poly(ADP-ribosylation). EMBO J. 4: 2129-2134.
60. GALE, K. C. & N. OSHEROFF. 1990. Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: Evidence for an active enzyme-cleaved DNA intermediate. Biochemistry 29(41): 9538-9545.
61. KNAB, A. M., J. FERTALA & M. A. BJORNSTI. 1995. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. J. Biol. Chem. 270: 6141-6148.
62. BJORNSTI, M. A., P. BENEDETTI, G. A. VIGLIANTI & J. C. WANG. 1989. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: Restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49: 6318-6323.